SLC7A11 and Hepatic fibrosis: Curcumol (Zheng et al., 2022), ellagic acid (Li et al., 2022), wogonoside (Liu et al., 2022), decursin, sorafenib, berberine, celastrol (Luo et al., 2022), isoliquiritigenin (Huang et al., 2022), DHA (Zhang et al., 2021), WBME (Ho et al., 2021), and chrysophanol (Kuo et al., 2020) alleviate liver fibrosis through inducing ferroptosis by inhibiting SLC7A11.